Abandon it if alternatives are available
A top official in the European Medicines Agency said it might be worth abandoning AstraZeneca's coronavirus vaccine for all age groups where alternatives are available, in an interview published yesterday.
Marco Cavaleri, the EMA's head of vaccine strategy, also told Italy's La Stampa newspaper that the Johnson & Johnson jab should be preferentially used for the over 60s.
Both so-called viral vector vaccines are authorised for everyone over 18 but have been dogged by reports of rare blood clots.
Asked if it would not be better to ban AstraZeneca including for the over 60s, Cavaleri said: "Yes, and it is an option that many countries are considering in the light of the increased availability of mRNA jabs."